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Abstract
Metabolic engineering and synthetic biology are synergistically related fields for manipu-
lating target pathways and designing microorganisms that can act as chemical factories.
Saccharomyces cerevisiae’s ideal bioprocessing traits make yeast a very attractive chem-
ical factory for production of fuels, pharmaceuticals, nutraceuticals as well as a wide
range of chemicals. However, future attempts of engineering S. cerevisiae’s metabolism
using synthetic biology need to move towards more integrative models that incorporate
the high connectivity of metabolic pathways and regulatory processes and the inter-
actions in genetic elements across those pathways and processes. To contribute in this
direction, we have developed Metabolic Engineering target Selection and best Strain
Identification tool (MESSI), a web server for predicting efficient chassis and regulatory
components for yeast bio-based production. The server provides an integrative platform
for users to analyse ready-to-use public high-throughput metabolomic data, which are
transformed to metabolic pathway activities for identifying the most efficient S. cerevi-
siae strain for the production of a compound of interest. As input MESSI accepts metab-
olite KEGG IDs or pathway names. MESSI outputs a ranked list of S. cerevisiae strains
based on aggregation algorithms. Furthermore, through a genome-wide association
study of the metabolic pathway activities with the strains’ natural variation, MESSI priori-
tizes genes and small variants as potential regulatory points and promising metabolic
engineering targets. Users can choose various parameters in the whole process such as
(i) weight and expectation of each metabolic pathway activity in the final ranking of the
strains, (ii) Weighted AddScore Fuse or Weighted Borda Fuse aggregation algorithm, (iii)
type of variants to be included, (iv) variant sets in different biological levels.
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Introduction
The suitability of Saccharomyces cerevisiae for the produc-
tion of a range of products, such as alcohols, acids, proteins
and hydrocarbons as well as pharmaceutical and nutraceut-
ical ingredients has been demonstrated numerous times. Its
attractiveness as a cell factory is mainly attributed to the
fast growth on relatively cheap carbon sources, the robust-
ness and tolerance towards harsh industrial conditions (e.g.
high osmotic stress and low pH) and the well-developed
genetics (1, 2). The continuous expansion of the genetic
toolbox available for S. cerevisiae allowing manipulation of
several genetic elements in a single round of transformation
for strain development has placed yeast as the preferred
host for bio-based production. Still, despite the several high-
profile ongoing projects in both academia and industry for
the use of S. cerevisiae to produce butanol, farnesene, stil-
benes and alkaloids, to name just a few products (3), there
is a clear need for the development of novel systemic
approaches for the optimal—in terms of yield, productivity
and final titer—functioning of the yeast metabolic network.
Metabolic engineering is exactly those integrated and
multidisciplinary approaches to regulate the performance
of the metabolic network for the cost-effective biological
manufacturing of industrially relevant products (4–6). The
field has clearly revolutionized by the explosion of infor-
mation regarding metabolic pathways, not only within the
genome of the host organism but essentially all organisms,
the availability of ‘omic’ data and systems level modelling
of function, however the integration with synthetic biology
is expected to offer great power in the design of platform
strains. Even though there has been a lot of debate in the
definition of the fields of metabolic engineering and syn-
thetic biology in principle the two disciplines are synergis-
tic but use fundamentally different approaches (6).
Metabolic engineering is a top-down approach for defining
which pathways and in which direction should be engin-
eered for the development of novel microbial capabilities
(7). On the other hand, synthetic biology, still regarded as
a young discipline, tends to be seen as a bottom-up
approach for improving the design of cell factories.
Propelled by the significant decrease in DNA sequencing
and synthesis cost, the improved understanding on geno-
type-to-phenotype relationships and standardization of
DNA assembly procedures, synthetic biology provides the
toolbox for constructing artificial elements to achieve par-
ticular functions. Applications of synthetic biology in yeast
metabolic engineering are expected to increase dramatic-
ally in the future thus development of publicly available
platforms that aim to capitalize on yeast’s natural diversity
for assembling biological parts with the desired properties
is of utmost importance.
Following this trend we present Metabolic Engineering
target Selection and best Strain Identification tool
(MESSI), a web server for predicting efficient chassis and
regulatory components for yeast bio-based production.
MESSI uses publicly available metabolomic data from
characterized S. cerevisiae strains for computing metabolic
pathway activities and ranks the strains based on user-
defined pathways of interest (single or multiple pathways).
Furthermore utilizing the natural variation between the
S. cerevisiae strains MESSI applies genome-wide associ-
ation mapping for identifying putative genes and other
genetic elements that correlate with the measured pheno-
type (metabolic pathway activity). MESSI is a user-friendly
platform and the output generated is easy to interpret
allowing the users to quickly select the most promising
plug-and-play S. cerevisiae strain for a specific product.
Candidate genes related with the pathway activity, e.g.
regulatory role in controlling metabolic fluxes towards
that product, are also provided.
Materials and methods
MESSI implemented two major tasks. First, metabolic path-
way activities were calculated based on large-scale metabo-
lomic measurements and strain rankings based on pathway
activities were further produced. Second, pathway activities
and genetic variants were used to predict the potential
metabolic engineering targets (variants or genes). The com-
putational pipeline is illustrated in Figure 1. The method-
ology and algorithms are described in detail as follows:
Data source and variant identification
Datasets compatible with MESSI are expected to encom-
pass metabolomic data from large-scale genetic studies.
Whole genome sequencing data are also included for pre-
dicting pathway activity associated variants and identify-
ing metabolic engineering targets.
Since large-scale population studies of yeast with both
genome and metabolome data available are still limited,
we incorporated one major dataset published in 2013 (8).
Based on this yeast database, 21 strains with both compar-
able metabolomic data and genomic data were selected
and this database was named as DB01_SC_21. As pathway
activities are expected to be affected by the growth condi-
tions, including carbon source, medium, temperature and
aeration conditions, all the relevant information are listed
in the server. It is recommended that users apply with cau-
tion the MESSI predictions for engineering strains for
which the cultivation conditions will be significantly differ-
ent from the ones used in the GWAS analysis here.
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To identify genetic variants (SNPs and InDels), all DNA
sequencing reads were mapped to the S288C reference
genome using BWA (9). Variant calling and filtering were
carried out by the Genome Analysis Toolkit (GATK)
(10, 11), with steps including RealignerTargetCreator,
IndelRealigner, UnifiedGenotyper (parameters: -stand_call_
conf 10.0 -stand_emit_conf 0 -deletions 1.0 -glm BOTH
-rf BadCigar) and VariantFiltration (parameters:–
filterExpression ‘ReadPosRankSum<8.0 jj FS>10.0’).
Variant effect annotation was carried out by SnpEff with
the S. cerevisiae database version EF4.69 (12). Variants
with low allele frequency (<0.05) were filtered due to pos-
sible sequencing or mapping errors, which would be detri-
mental to further analysis on genome-wide association and
linkage disequilibrium (LD).
Pathway activity calculation and pairwise
correlations
The pathway activity profiling (PAPi) algorithm (13) was
employed for calculating pathway activity based on metab-
olomic data. As data normalization is required by PAPi,
compound concentrations were converted into ratios to the
mean value of all strains. Over 100 pathway activity scores
were generated for each strain. Pathways absent in Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway
database for S. cerevisiae were removed (14).
To provide users a wider range of potential metabolic en-
gineering targets, MESSI is designed to identify variants and
genes in correlated pathways, which associate significantly
with the target metabolic pathway in terms of the
metabolome-based pathway activities. The universal path-
ways, including ‘Metabolic pathways’, ‘Biosynthesis of sec-
ondary metabolites’, ‘Microbial metabolism in diverse
environments’, ‘Carbon metabolism’, ‘2-Oxocarboxylic acid
metabolism’, ‘Fatty acid metabolism’, ‘Biosynthesis of
amino acids’, ‘Degradation of aromatic compounds’, ‘ABC
transporters’ and ‘Aminoacyl-tRNA biosynthesis’, were
excluded in pathway activity correlation analysis. The pair-
wise Pearson correlation coefficients and P values were cal-
culated with R (15). P values were further adjusted to Q
values using Bonferroni correction for multiple compari-
sons, and the significance level was set to Q<0.05. Around
7% (78/1081) of the pairwise comparisons were shown sig-
nificant correlation, calculated for 47 non-universal path-
ways with activity scores in the DB01_SC_21 database.
Pathway activity aggregation and strain ranking
To generate a unified ranking of strains based on user-
defined pathways, pathway activity aggregation is
performed. Since the raw pathway activity scores (PA)
generated from PAPi for different pathways are not
comparable, they are further linearly normalized to 0–1, as
normalized pathway activity scores (PAN), before aggrega-
tion. For strain i and pathway j, PANi,j is calculated by the
following formula:
PANi;j ¼ PAi;j  PAmin;j
PAmax;j  PAmin;j
For each target pathway, two parameters, pathway ac-
tivity expectation (E) and weight (W), are provided from
Figure 1. The computational pipeline of the MESSI server. Green boxes represent inputs and outputs. Data inside the blue dotted box have been pre-
calculated from the exsisting database (DB01_SC_21) on the MESSI server. Steps inside the orange dotted box are user defined analysis.
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the user. Expectation (E) is to characterize how active the
target pathway should be. Three options are available,
including Very Active, Medium and Very Weak. Their cor-
responding values in the aggregation algorithm are E¼ 1,
0.5 and 0, respectively. For example, when E is set to 1,
the strain with the highest pathway activity score
(PAN¼1) will rank first for the selected pathway; while if
it is set to 0, the strain with PAN¼ 0 will rank the first;
when it is set to 0.5, the strain with PAN nearest to 0.5
will rank the first, and the strains with strongest or weakest
pathway activity will be in the bottom. The transferred
pathway activity score (PAT) generated for strain i
and pathway j is calculated as follows:
PATi;j ¼ 1  jEj  PANi;j j
Another important parameter, weight (W), is to charac-
terize the relative importance of a particular pathway com-
pared with other pathways in aggregation. It can be any
non-negative number used as weight during aggregation.
When more than one pathways are targeted, aggregation
will be carried out for strain ranking. By default, universal
pathways defined in the previous section, like ‘Metabolic
pathway’, will receive a weight of 0 in aggregation. Users
can also revise this default setting to a positive number
when universal pathways are taken into consideration.
Two optional algorithms for aggregation are provided
and they are the Weighted AddScore Fuse (WASF) (the de-
fault option) and Weighted Borda Fuse (WBF) (16). In the
ranking process, WBF only considers pathway activity
rankings (based on scores), while WASF directly uses the
scores (PAT).





When WBF is used for strain i and pathway j, Bi,j is the
sum of strains with lower PAT than strain i. The fused





Finally, a strain ranking based on user-defined path-
ways will be generated based on FS.
Genome-wide association study on pathway
activities
MESSI incorporated information of compounds, pathways
and genes and their relationships from KEGG database
using KEGG API REST.
To identify candidate pathway activities affecting vari-
ants and genes, which could serve as potential metabolic en-
gineering targets, an association study was performed. The
variant information for different strains is retrieved and
integrated from the variant calling pipelines described in the
previous section. The pathway activities calculated for
diversified pathways are used for different phenotypic indi-
cators. Among the 21 strains in DB01_SC_21, GWAS was
performed for 54 sets of pathway activities. The number of
yeast strains used for the GWAS in the present study is com-
parable to previous studies reported in the literature (8, 17).
At variant (SNP or InDel) level, the efficient mixed-
model association (EMMA) method was adopted to calcu-
late genetic relatedness to pathway activities (18). As
adjusted permutation test P values are provided by
EMMA, the significance threshold is set to P< 0.05, for
further gene-level variant statistics.
To prioritize gene level targets, gene-level association
P values were calculated based on significant LD blocks
and proxy clusters (19). LD blocks were generated by the
Haploview by applying the Four Gamete Rule (20). In gen-
eral, by applying this method, the most significant variant
in overlapping LD blocks were considered as the true asso-
ciation of a gene.
Besides gene-level P values, other indices, such as statistics
on variant quantities of diverse effects, and variant signifi-
cant level accumulated score (AS), are also provided to users.
They serve as alternative candidates for potential metabolic






Where Li stands for the length of the gene i region (800 bp
upstream sequence is included as potential regulatory re-
gion), and Pi,j stands for the P value for significant variant
j in gene i.
Server description
MESSI was written in R and PHP, running under the
Debian 7 Linux environment. Stylesheets and functions of
Shiny R package were introduced (21). There is no login
requirement to use MESSI. Finished jobs are stored for two
years and can be viewed using job ID. The interface and
workflow of MESSI are illustrated in Figure 2. There are
three main steps to run MESSI as follows:
Input: pathway or compound list and parameters
Two input formats, KEGG pathway names and KEGG
compound IDs, are acceptable in MESSI (Figure 2A). Users
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can select the input pathways from a candidate list on the
web server. Examples for the two types of input are avail-
able for testing.
Variants and genes associated with input pathways or
compounds could be summarized and demonstrated in dif-
ferent biological levels, serving as potential metabolic engin-
eering targets. Optional levels include: (i) level 0, no variant
and gene information will be processed; (ii) level 1, variants
and genes in metabolic reactions of target compounds (only
when input is a compound list); (iii) level 2, variants and
genes in target pathways associated with their pathway ac-
tivity score; (iv) level 3, variants and genes in correlated
pathways associated with their activity scores; (v) level 4,
variants and genes in whole genome level associated with
activity in target pathways. When a higher level is chosen,
data from lower levels are automatically processed.
Variants (SNPs and InDels) could be filtered optionally
according to their mutation effects/positions, including up-
stream non-coding variants, synonymous coding (including
synonymous amino acid coding codon or synonymous stop
codon), missense coding, nonsense variants (stop-codon
gained, start- or stop-codon lost situations), frame shifts,
codon insertions or deletions, variants in intron and vari-
ants in splice sites.
Second step: pathway expectation and weight
adjustment
In this step, ‘Expectation’ of pathway activity, defined as
how active the target pathway should be, and ‘Weight’ of
pathway activity, defined as the relative importance of the
pathway compared with others in aggregation, are seleted
Figure 2. The interface of MESSI and the workflow of running a task. (A) Create a new task by the following steps: name a job, select a strain database,
input target pathway list or compound list, and set the parameters on the potential metabolic engineering targets identification and variant calling.
(B) Set the pathway expectations and weights and choose an aggregation algrithm. (C) Check for the results, including job information, best strains,
metabolic engineering targets (gene-level and variant-level, respectively), fused score, ranking and variant list of each strain.
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for target pathways (Figure 2B). When the input is a path-
way list, all recognized pathways will be listed as target
pathways. If the input is a compound list, pathways associ-
ated with target compounds in KEGG database will be
listed. There are four reasons why pathways or compounds
may be marked as ‘unrecognized or unused compounds or
pathways’: (i) their input IDs or names could not be recog-
nized by KEGG; (ii) the input IDs or names are recognized
but are not part of the S. cerevisiae KEGG database; (iii)
no pathway activity scores could be calculated due to data
incompleteness in the metabolomic profiling of these path-
ways; (iv) for recognized compounds, pathway activity
scores are not available for all associated pathways (similar
to (iii)).
For recognized pathways, expectation (E) can be set as
very weak, medium or very active. Weight (W) can be any
non-negative value. Weight for universal pathways is set to
0 by default. ‘Call Variants’ should be selected if metabolic
engineering targets (variants and genes) are supposed to be
presented for the target pathways.
Users can also select two optional pathway activity ag-
gregation algorithms, WBF and WASF in this step (16).
Output: strain ranking, variants and gene-level
metabolic engineering targets
In the result page, job information including job ID, input
type, database and parameters are provided (Figure 2C).
Based on the fused scores, the best strains (top 5) are iden-
tified and a table with scores and rankings of all strains
will be listed (Figure 2C).
If the user would like to search for potential metabolic
engineering targets, two types of information, variant and
gene-level information, will be provided in the results.
Generally, variant information may include three main
parts, (i) an eight-column basic information (including
chromosome, position, variant type, reference genotype,
variant genotype, gene id, variant effect and amino acid al-
teration), (ii) a data matrix of strains (for database
DB01_SC_21 it is a 21-column matrix, with 0/1 represent-
ing the variant is/is not observed in the corresponding
strain, respectively) and (iii) a matrix of P values of associ-
ations with pathway activities. For strain-specific variant
list, the data matrix of strains is not presented and only
variants captured in the target strain will be listed. For
pathway-specific variant list, there will be only one column
of association P values of the specific pathway. The variant
list will be sorted by P values, so significantly associated
variants will be shown first.
Gene-level information includes gene IDs, gene-level P
values, significance level AS, gene region lengths, total
variant numbers, significant variant numbers and statistics
for diverse effects. This information is sorted by P values
thus genes with the highest significance levels from their
LD blocks will rank first.
In the score and ranking table, strain-specific variant
lists are shown in selected biological levels. In the
‘Metabolic Engineering Target Selection’ table, relation-
ships among compounds, pathways, correlated pathways
and genes are available (Figure 2C). All input and corre-
lated sources are listed in a tree structure with hyperlinks
to the corresponding KEGG information. Variant and gene
lists have been generated for different sources. Top 3 asso-
ciated genes of P value-based and AS-based rankings
are listed, with hyperlinks to the corresponding informa-
tion in Saccharomyces Genome Database (SGD) (22).
Strain names are also attached with hyperlinks to the
British National Collection of Yeast Cultures (23), for
facilitating downstream wet-lab engineering strategies.
Evaluation
Experimental verification using published studies
To evaluate the reliability of MESSI in the prediction of
metabolic engineering targets, we run a number of tasks
and confirmed the correlations with experimental studies
in the literature. All the studies presented here were per-
formed under the same aeration condition (aerobic) and
carbon source (glucose) as the strain characterization in
our current pathway activity database.
Metabolic engineering to enhance fatty acid production
in S. cerevisiae is a ‘hot’ topic for years. We created a job
named ‘eg_fattyacid’, with the input pathway list including
‘Fatty acid metabolism’, ‘Fatty acid biosynthesis’, ‘Fatty
acid degradation’ and ‘Fatty acid elongation’. ‘Fatty acid
degradation’ was marked as unused pathway and ‘Fatty
acid metabolism’ was marked as a universal pathway. For
the ‘Fatty acid biosynthesis’, the pathway ‘Biosynthesis of
unsaturated fatty acids’ was found as correlated pathway
based on their activity scores. For ‘Fatty acid elongation’,
‘Biosynthesis of unsaturated fatty acids’ and ‘Arginine and
proline metabolism’ were captured as significantly corre-
lated. Two lists of top 3 genes (in P value-based or AS-
based rankings, respectively) were generated for the two
target pathways and the two correlated pathways. In a re-
cently published study (24), eight genes were experimen-
tally verified to be strongly correlated with fatty acid
production by either gene deletion or overexpression. The
genes FAA1, FAA2 (24, 25), FAS1 and FAS2 (26) were
shown to have direct correlation with fatty acid produc-
tion. In FAA1 and FAA4 disrupted strain, approximately
80 mg/l fatty acids can be produced (25) whereas knock-
outs of FAA2, PXA1 and POX1, increased the
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intracellular fatty acids levels by 55% (24). Similarly, the
levels of lignoceric acid and cerotic acid were largely
increased (40 and 50%, respectively) by the fas1D strain
(26). Among these, FAA2 and FAA1 were successfully cap-
tured by MESSI in the top 3 in target pathway ‘Fatty acid
biosynthesis’, and POX1 was found in the top-3 in corre-
lated pathway ‘Biosynthesis of unsaturated fatty acids’.
PXA1, which was also experimentally shown as a regula-
tory point of fatty acid production, is not part of any of
these pathways, however, in our analysis it was found sig-
nificantly associated with the pathway activity of ‘Fatty
acid biosynthesis’ and was ranked fourth in the whole-gen-
ome level statistics. DGA1 is a similar to the PXA1 case
and was found significantly associated to the pathway
‘Fatty acid elongation’ in the whole-genome level statistics.
Another example is the NADþ/NADH metabolism,
with the levels of NADþ/NADH to play important roles in
yeast lifespan and have significant influence on efficient
carbon source utilization (27). The job ID of this test ex-
ample was ‘eg_NAD’ and the input was compound list
(C00003: NADþ). Three target pathways, ‘Nicotinate and
nicotinamide metabolism’, ‘Thiamine metabolism’ and
‘Oxidative phosphorylation’, were identified and pro-
cessed. In the most relevant pathway, ‘Nicotinate and nico-
tinamide metabolism’, all the five genes from the two top 3
lists (with one gene shared by both rankings) have been ex-
perimentally shown to be strongly correlated with the
NADþ concentration [HST1, HST4 (28), PNC1 (29),
NRK1 (30) and BNA6 (31)]. More specifically, the dele-
tion of HST1 resulted in up to 71% increase in NADþ lev-
els (28). On the contrary, the Dnrk1 and Dpnc1 double-
mutant strain incapable of incorporating supplemented
nicotinamide riboside (NR) into NADþ in nicotinic-acid-
free media (30). The Dpnc1 mutant contributed to 69.9%
decrease in the intracellular NADþ concentration in sta-
tionary phase (29), while kynurenine and 3-(OH)-kynure-
nine in the cell, which are precursors of NADþ from
kynurenine pathway, were absent in the Dbna6 mutant
(31).
In silico verification from Genome-scale metabolic
model (GEM) simulations
We carried out in silico simulations to evaluate the univer-
sal gene ranking results systematically. Null mutant simu-
lations were executed using the yeast genome-scale
metabolic model iTO977 (32) by the RAVEN Toolbox
(33). The glucose uptake rate was set to 10 mmol/g/h and
the simulations were optimized for maximum growth. For
the original model and each single gene deletion simula-
tions, all reaction fluxes were calculated and then summar-
ized by individual non-universal pathways. Reactions
without any perturbation in all simulations, and pathways
without valid activity information or with less than 6 simu-
lated reactions were removed in the statistical analysis. 40
pathways were processed, with 21.5 genes, 28.8 reactions
and 10.7 reserved reactions on average. We assumed the
fluxes of a reaction among all 977 single gene deletion
simulations have a normal distribution (with the popula-
tion mean the flux of the original model) thus we con-
verted all fluxes into Z-scores and calculated their
P values. The proportions of significantly altered fluxes
(P< 0.05) were compared between the top 3 genes from
the P value-based ranking, and the rest of the genes for
each pathway, respectively. It was observed that the pro-
portions of significantly altered fluxes of the top ranked
genes are significantly higher than the rest ones in single
gene deletion simulations (3.49% versus 1.87, T-test
P¼ 0.022), illustrating the potential regulatory role of the
MESSI output.
Conclusions and future directions
The ability to perform deep sequencing of industrially rele-
vant microbial species at increasingly affordable costs can
help to revolutionize microbial cell factory engineering in a
similar way that revolutionized fields like human genetics
and epigenetic studies. With this in mind, we developed
MESSI, a S. cerevisiae web server, where we incorporated
bioinformatics methods—that are being employed in NGS-
based human genetics—for prioritizing genetic changes
that need to be experimentally tested. The ultimate goal of
MESSI is to provide a more solid and comprehensive basis
for selecting the most promising host for desired pheno-
types and discover which mutations would be expected to
contribute most to that phenotype for metabolic engineer-
ing efforts. We believe that MESSI offers new opportuni-
ties for establishing links between genotype and phenotype
in S. cerevisiae strains and can be efficiently used for
searching genome-wide spaces for small variants and genes
conferring phenotypic characteristics of interest.
The first version of MESSI contains 21 S. cerevisiae
strains for best strain selection and genotype-to-phenotype
mapping. Even though the number of yeast strains is com-
parable with other studies in the literature (8, 17) we in-
tend to significantly expand the S. cerevisiae strain
database to achieve higher confidence in the GWAS map-
ping and improve the prediction of regulatory points in the
different metabolic pathways. Towards that objective we
have initiated a collaborative effort to sequence the gen-
omes and perform metabolomic profiling of >35 S. cerevi-
siae strains, including several industrial strains. To deal
with the limitation of KEGG database and the ready-made
definition of its pathways, a further direction of MESSI
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may be a comprehensive expansion of pathway databases
(for instance, Reactome (34), SGD (22), etc.).
Furthermore, based on the better-defined pathways and
the in-house strain set, we will work on an algorithm de-
velopment to compute the optimized pathway expectation
(E) and weights (W) automatically from the pathway top-
ology, and then evaluate the method with downstream en-
gineering in our strain set. Last but not least, we will
continuously add more strain databases from different cul-
tivation conditions, for instance, diverse carbon sources
(ethanol is next in the pipeline) and cultivation conditions
(batch cultivation, anaerobic, etc.), to improve the prac-
tical value of MESSI in industrial bioengineering.
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